Interesting new method & results from the Lindquist lab that exploits the interaction between chaperones and client proteins to monitor drug interactions in cells. Small molecules stabilize target protein conformation, leading to reduced chaperone binding which in turn can be detected be reduced target-chaperone co-IP.